NEXGEL, INC. Investment Income, Net
NEXGEL, INC. (NXGL) reported Investment Income, Net of $1.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2023-11-13
- NEXGEL, INC. investment income, net for the quarter ending 2023-09-30 was $1.00K.
- NEXGEL, INC. investment income, net for the quarter ending 2023-06-30 was $2.00K.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month |
|---|---|---|---|
| 2023-09-30 | $1.00K 10-Q · filed 2023-11-13 | $3.00K derived: sum of 2 quarters · filed 2023-11-13 | $3.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $2.00K 10-Q · filed 2023-08-14 | $2.00K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |